Medication for the treatment of HIV/AIDS
"Telura" redirects here. For the genus of scarab beetles, see
Liparetrini .
Pharmaceutical compound
Efavirenz/lamivudine/tenofovir (EFV/3TC/TDF ), sold under the brand name Symfi among others, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS .[ 1] [ 2] [ 3] efavirenz , lamivudine , and tenofovir disoproxil .[ 3] [update] World Health Organization as an alternative first line option to dolutegravir/lamivudine/tenofovir .[ 4] by mouth .[ 1] [ 2] [ 3]
Side effects can include joint pain, sleepiness, headaches, depression, trouble sleeping, and itchiness.[ 3] depression , psychosis , or osteonecrosis .[ 3] epilepsy , it may increase the frequency of seizures .[ 3] kidney problems .[ 3] pregnancy appears to be unsafe.[ 1] [ 2]
It is on the World Health Organization's List of Essential Medicines .[ 5] [ 6] [ 7] [ 8] Medecins Sans Frontieres .[ 3] generic medication .[ 9] [ 10] [ 11]
References
^ a b c d "Symfi- efavirenz, lamivudine and tenofovir disoproxil fumarate tablet, film coated" . DailyMed . Retrieved 25 September 2021 .^ a b c d "Symfi Lo- efavirenz, lamivudine and tenofovir disoproxil fumarate tablet, film coated" . DailyMed . Retrieved 25 September 2021 .^ a b c d e f g h "Efavirenz + lamivudine + tenofovir disoproxil fumarate (Addition) -- Adults" . World Health Organization (WHO)the original on October 26, 2015.^ World Health Organization (July 2019). Policy brief: update of recommendations on first- and second-line antiretroviral regimens . World Health Organization. hdl :10665/325892 ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019 . Geneva: World Health Organization. hdl :10665/325771 ^ "HIV/AIDS History of Approvals - HIV/AIDS Historical Time Line 2010 - 2015" . U.S. Food and Drug Administration (FDA) . Archived from the original on February 27, 2016. Retrieved 13 December 2017 .^ "Drug Approval Package: Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate)" . U.S. Food and Drug Administration (FDA) . 9 October 2018. Archived from the original on April 15, 2021. Retrieved 15 August 2020 .^ "Drug Approval Package: Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate)" . U.S. Food and Drug Administration (FDA) . 24 November 2018. Retrieved 15 August 2020 .[dead link ^ "Office of Generic Drugs 2020 Annual Report" . U.S. Food and Drug Administration (FDA) . Retrieved 12 February 2021 .[dead link ^ "Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate: FDA-Approved Drugs" . U.S. Food and Drug Administration (FDA) . Archived from the original on October 19, 2020. Retrieved 25 September 2021 .^ "Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate: FDA-Approved Drugs" . U.S. Food and Drug Administration (FDA) . Archived from the original on October 19, 2020. Retrieved 25 September 2021 .
External links
